Mehrdad R Majlessi

This inventor holds 32 USPTO granted patents and 9 published patent applications, plus 14 CIPO patents and 12 EPO patents, primarily in Nucleic Acid Detection. Top assignees: Gen-Probe, Inc., Bank of America, N.a., as Collateral Agent. Active years: 2000-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mehrdad R Majlessi. Retrieved from https://idiyas.com/inventor/mehrdad-r-majlessi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 9)

% Patents Active = 87.5

CIPO Patents = 14 (Patent Applications = 5)

EPO Patents = 12 (Patent Applications = 19)

Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 494(Granted Patents)

Location History:

San Diego, CA (US) (2000 - 2008)
Escondido, CA (US) (2003 - 2024)

Company Filing History:

Bank of America, N.a., as Collateral Agent

patents

Years Active: 2000-2026

Loading Chart...

Areas of Expertise:

Nucleic Acid Detection

Viral Pathogens

Modified Probes

Adenovirus

Parainfluenza Virus

Rhinovirus

Amplification Methods

Capture Probes

Far-Red Dye Probes

Biological Samples

Kits and Compositions

Oligonucleotide Probes

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735737 - Far-Red Dye Probe Formulations (2026-09-15),

2. 12649950 - COMPOSITIONS AND METHODS FOR DETECTION OF VIRAL PATHOGENS IN SAMPLES (2026-06-09),

3. 12497655 - COMPOSITIONS, METHODS AND KITS TO DETECT ADENOVIRUS, METAPNEUMOVIRUS AND/OR RHINOVIRUS NUCLEIC ACIDS (2025-12-16),

4. 12460255 - Compositions and methods to detect adenovirus nucleic acids and metapneumovirus and/or rhinovirus nucleic acids (2025-11-04),

5. 12428672 - Compositions and methods for detecting or quantifying Human Parainfluenza Virus 4 (2025-09-30),

6. 12404541 - Compositions and methods for detecting or quantifying human parainfluenza virus 2 (2025-09-02),

7. 12398420 - Compositions to detect adenovirus nucleic acids (2025-08-26),

8. 12338491 - Methods to detect rhinovirus nucleic acids (2025-06-24),

9. 12139706 - Method of nonspecific target capture of nucleic acids (2024-11-12),

10. 12116620 - Compositions and methods for detecting or quantifying parainfluenza virus (2024-10-15),

11. 11976337 - Methods for detection of influenza in samples (2024-05-07),

12. 11499193 - Far-red dye probe formulations (2022-11-15),

13. 11384387 - Compositions, methods and kits to detect adenovirus nucleic acid (2022-07-12),

14. 11035012 - Capture probes immobilizable via L-nucleotide tail (2021-06-15),

15. 10900033 - Method of nonspecific target capture of nucleic acids (2021-01-26),

Title: Mehrdad R Majlessi: Pioneering Innovator in Escondido, CA

Introduction:

Mehrdad R Majlessi, a distinguished inventor based in Escondido, CA, is renowned for his unwavering commitment to innovation and his relentless pursuit of excellence in the field. His pioneering spirit has not only led to groundbreaking inventions but has also inspired countless individuals to push the boundaries of what is deemed possible.

Latest Patents:

Among his impressive portfolio of 22 patents, Mehrdad R Majlessi's latest innovations include "Methods for detection of influenza in samples." This patent encompasses amplification primers, hybridization assay probes, and associated reagents for analyzing samples for the presence of various target nucleic acids. Additionally, he holds a patent for "Far-red dye probe formulations," which features formulations comprising a far-red dye probe and a non-linear surfactant or foamban, alongside methods for preparing such formulations.

Career Highlights:

Mehrdad R Majlessi is a valued member of Gen-Probe, Inc., a leading company in the field of biotechnology and diagnostics. His contributions to the company have been instrumental in driving forward advancements in molecular diagnostics, particularly in the detection of infectious diseases.

Collaborations:

Throughout his career, Mehrdad R Majlessi has collaborated closely with esteemed colleagues such as Michael McClellan Becker and Steven T Brentano. Together, they have engaged in cutting-edge research and development initiatives that have significantly impacted the field of biotechnology.

Conclusion:

In conclusion, Mehrdad R Majlessi's dedication to innovation and his exceptional track record of inventive achievements solidify his position as a standout inventor in Escondido, CA. His pioneering spirit, coupled with his collaborative efforts and commitment to excellence, continues to shape the landscape of molecular diagnostics and inspire future generations of innovators.

Profile summary based on public USPTO records.